Capital International Investors Vir Biotechnology, Inc. Transaction History

Capital International Investors

  • $483 Billion
  • Q1 2024

A detailed history of Capital International Investors transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Capital International Investors holds 258,400 shares of VIR stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
258,400
Previous 258,400 -0.0%
Holding current value
$2.3 Million
Previous $2.6 Million 0.69%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$18.26 - $31.1 $43.9 Million - $74.7 Million
-2,402,282 Reduced 90.29%
258,400 $4.98 Million
Q2 2022

Aug 15, 2022
SELL
$19.08 - $26.7 $31.8 Million - $44.6 Million
-1,668,834 Reduced 38.55%
2,660,682 $67.8 Million
Q1 2022

May 16, 2022
SELL
$21.19 - $40.01 $24.9 Million - $47.1 Million
-1,176,050 Reduced 21.36%
4,329,516 $111 Million
Q4 2021

Feb 14, 2022
SELL
$30.97 - $54.03 $99.7 Million - $174 Million
-3,218,090 Reduced 36.89%
5,505,566 $231 Million
Q3 2021

Nov 15, 2021
SELL
$34.9 - $54.54 $109 Million - $170 Million
-3,120,377 Reduced 26.35%
8,723,656 $380 Million
Q2 2021

Aug 16, 2021
BUY
$38.75 - $51.0 $824,212 - $1.08 Million
21,270 Added 0.18%
11,844,033 $560 Million
Q1 2021

May 14, 2021
BUY
$26.34 - $83.07 $13.7 Million - $43.4 Million
521,959 Added 4.62%
11,822,763 $606 Million
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $451,782 - $768,259
17,710 Added 0.16%
11,300,804 $303 Million
Q3 2020

Nov 13, 2020
BUY
$28.28 - $53.6 $288 Million - $546 Million
10,188,789 Added 931.07%
11,283,094 $387 Million
Q1 2020

May 15, 2020
BUY
$12.04 - $60.2 $1.34 Million - $6.68 Million
111,005 Added 11.29%
1,094,305 $37.5 Million
Q4 2019

Feb 18, 2020
BUY
$11.83 - $15.85 $11.6 Million - $15.6 Million
983,300 New
983,300 $12.4 Million

Others Institutions Holding VIR

# of Institutions
225
Shares Held
88.2M
Call Options Held
177K
Put Options Held
182K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.18B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email